Literature DB >> 35339437

Of axons that struggle to make ends meet: Linking axonal bioenergetic failure to programmed axon degeneration.

Elisabetta Babetto1, Bogdan Beirowski2.   

Abstract

Axons are the long, fragile, and energy-hungry projections of neurons that are challenging to sustain. Together with their associated glia, they form the bulk of the neuronal network. Pathological axon degeneration (pAxD) is a driver of irreversible neurological disability in a host of neurodegenerative conditions. Halting pAxD is therefore an attractive therapeutic strategy. Here we review recent work demonstrating that pAxD is regulated by an auto-destruction program that revolves around axonal bioenergetics. We then focus on the emerging concept that axonal and glial energy metabolism are intertwined. We anticipate that these discoveries will encourage the pursuit of new treatment strategies for neurodegeneration.
Copyright © 2022 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ATP; Axon degeneration; Glia; Monocarboxylate transporter; Schwann cells; Wallerian degeneration

Mesh:

Year:  2022        PMID: 35339437      PMCID: PMC9186470          DOI: 10.1016/j.bbabio.2022.148545

Source DB:  PubMed          Journal:  Biochim Biophys Acta Bioenerg        ISSN: 0005-2728            Impact factor:   4.428


  89 in total

1.  Targeting NMNAT1 to axons and synapses transforms its neuroprotective potency in vivo.

Authors:  Elisabetta Babetto; Bogdan Beirowski; Lucie Janeckova; Rosalind Brown; Jonathan Gilley; Derek Thomson; Richard R Ribchester; Michael P Coleman
Journal:  J Neurosci       Date:  2010-10-06       Impact factor: 6.167

2.  Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum.

Authors:  Wakoto Matsuda; Takahiro Furuta; Kouichi C Nakamura; Hiroyuki Hioki; Fumino Fujiyama; Ryohachi Arai; Takeshi Kaneko
Journal:  J Neurosci       Date:  2009-01-14       Impact factor: 6.167

3.  The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD+ Cleavage Activity that Promotes Pathological Axonal Degeneration.

Authors:  Kow Essuman; Daniel W Summers; Yo Sasaki; Xianrong Mao; Aaron DiAntonio; Jeffrey Milbrandt
Journal:  Neuron       Date:  2017-03-22       Impact factor: 17.173

4.  The Divergent Roles of Dietary Saturated and Monounsaturated Fatty Acids on Nerve Function in Murine Models of Obesity.

Authors:  Amy E Rumora; Giovanni LoGrasso; John M Hayes; Faye E Mendelson; Maegan A Tabbey; Julia A Haidar; Stephen I Lentz; Eva L Feldman
Journal:  J Neurosci       Date:  2019-03-18       Impact factor: 6.167

5.  Initial-rate kinetics of human NMN-adenylyltransferases: substrate and metal ion specificity, inhibition by products and multisubstrate analogues, and isozyme contributions to NAD+ biosynthesis.

Authors:  Leonardo Sorci; Flavio Cimadamore; Stefania Scotti; Riccardo Petrelli; Loredana Cappellacci; Palmarisa Franchetti; Giuseppe Orsomando; Giulio Magni
Journal:  Biochemistry       Date:  2007-04-03       Impact factor: 3.162

6.  Why do axons differ in caliber?

Authors:  János A Perge; Jeremy E Niven; Enrico Mugnaini; Vijay Balasubramanian; Peter Sterling
Journal:  J Neurosci       Date:  2012-01-11       Impact factor: 6.167

7.  The NAD+-mediated self-inhibition mechanism of pro-neurodegenerative SARM1.

Authors:  Yuefeng Jiang; Tingting Liu; Chia-Hsueh Lee; Qing Chang; Jing Yang; Zhe Zhang
Journal:  Nature       Date:  2020-10-14       Impact factor: 49.962

8.  Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis.

Authors:  Simon Licht-Mayer; Graham R Campbell; Marco Canizares; Arpan R Mehta; Angus B Gane; Katie McGill; Aniket Ghosh; Alexander Fullerton; Niels Menezes; Jasmine Dean; Jordon Dunham; Sarah Al-Azki; Gareth Pryce; Stephanie Zandee; Chao Zhao; Markus Kipp; Kenneth J Smith; David Baker; Daniel Altmann; Stephen M Anderton; Yolanda S Kap; Jon D Laman; Bert A 't Hart; Moses Rodriguez; Ralf Watzlawick; Jan M Schwab; Roderick Carter; Nicholas Morton; Michele Zagnoni; Robin J M Franklin; Rory Mitchell; Sue Fleetwood-Walker; David A Lyons; Siddharthan Chandran; Hans Lassmann; Bruce D Trapp; Don J Mahad
Journal:  Acta Neuropathol       Date:  2020-06-22       Impact factor: 17.088

9.  Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration.

Authors:  Andrea Loreto; Ciaran S Hill; Victoria L Hewitt; Giuseppe Orsomando; Carlo Angeletti; Jonathan Gilley; Cristiano Lucci; Alvaro Sanchez-Martinez; Alexander J Whitworth; Laura Conforti; Federico Dajas-Bailador; Michael P Coleman
Journal:  Neurobiol Dis       Date:  2019-11-15       Impact factor: 5.996

10.  Live imaging reveals the cellular events downstream of SARM1 activation.

Authors:  Kwang Woo Ko; Laura Devault; Yo Sasaki; Jeffrey Milbrandt; Aaron DiAntonio
Journal:  Elife       Date:  2021-11-15       Impact factor: 8.140

View more
  1 in total

Review 1.  Metabolic and Cellular Compartments of Acetyl-CoA in the Healthy and Diseased Brain.

Authors:  Agnieszka Jankowska-Kulawy; Joanna Klimaszewska-Łata; Sylwia Gul-Hinc; Anna Ronowska; Andrzej Szutowicz
Journal:  Int J Mol Sci       Date:  2022-09-03       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.